<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02415309</url>
  </required_header>
  <id_info>
    <org_study_id>NMCSD.2015.0048</org_study_id>
    <nct_id>NCT02415309</nct_id>
  </id_info>
  <brief_title>Premedication With Melatonin in Lumbar Medial Branch Block Procedure</brief_title>
  <official_title>Premedication With Melatonin vs. Placebo in Patients Undergoing Interventional Pain Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Naval Medical Center, San Diego</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Naval Medical Center, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lumbar medial branch blocks are commonly used as a diagnostic tool for facet-mediated chronic
      low back pain. This interventional pain procedure often occurs in the fluoroscopy suite.
      During this procedure, a physician inserts the needles to deliver local anesthetics such as
      lidocaine or bupivacaine to the nerves which innervate the lumbar facet joint. Many patients
      experience anxiety before and during the lumbar medial branch block procedure and require
      intravenous midazolam or fentanyl for sedation. Intravenous or conscious sedation requires
      one-to-one nursing care, monitoring, and recovery. In order to minimize the costs and time
      requirements of intravenous sedation, a suitable oral medication which is readily available
      and non-controlled would be ideal. Several randomized double-blinded, controlled trials have
      investigated the anxiolytic effects of melatonin before a surgery; however no studies to date
      have studied the anxiolytic effects of melatonin before less invasive interventional pain
      procedures. This study is designed to evaluate the efficacy of melatonin for reducing anxiety
      in patients undergoing a lumbar medial branch block procedure.

      The study is a randomized, double-blinded, placebo-controlled trial with 40 patients in each
      group: 2 mg melatonin, 10 mg melatonin and placebo. The primary outcome is anxiety reduction
      in patients before undergoing the procedure. The primary outcome is measured by visual
      numerical rating scale for anxiety and the Amsterdam Preoperative Anxiety and Information
      Scale. Based on the results of previous studies, the investigators hypothesize that melatonin
      may reduce anxiety in patients undergoing the procedure and be a suitable alternative to
      intravenous sedation in the pain clinic for patients undergoing lumbar medial branch blocks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic low back pain is a common disease in industrialized countries which affect patients'
      productivity and quality of life. Currently, the estimated yearly prevalence of chronic low
      back pain in United States is 5-20%. Lumbar medial branch blocks (LMBB) are commonly used as
      a diagnostic tool for facet mediated chronic low back pain. This interventional pain
      procedure often occurs in the fluoroscopy suite. During this procedure, a physician inserts
      the needles to deliver local anesthetics such as lidocaine or bupivacaine to the nerves which
      innervate the lumbar facet joint.

      Many patients experience anxiety before the LMBB procedure and require intravenous midazolam
      or fentanyl for sedation. In fact, in a retrospective review of over 8,000 interventional
      fluoroscopically guided pain procedures, the highest incidence of vasovagal episodes occurred
      with LMBB procedures. A nurse is required to administer these medications and monitor
      patient's vital signs. In addition, recovery from these medications can unduly prolong the
      patients visit and, in the case of fentanyl, can confound the diagnostic utility of the LMBB
      procedure by decreasing patient's pain.

      In an effort to minimize the cost of administration, monitoring, time of recovery and
      maximize the diagnostic utility of LMBBs, a suitable alternative is required. Several
      randomized, double-blinded, controlled trials investigate the anxiolytic effect of melatonin
      before a surgery. Several other studies and review articles describe the use of melatonin for
      both sedation and anxiolysis in both adults and children. However, no studies to date
      describe the use of melatonin for anxiolysis or sedation for interventional pain medicine
      procedures.

      Melatonin ((N-acetyl-5-methoxytryptamine) is an over-the-counter product which patients can
      take to reduce anxiety before a procedure; it is a hormone produced in the pineal gland and
      secreted into the blood and cerebrospinal fluid. Melatonin has several functions including
      the regulation of circadian rhythms and regulation of the reproductive axis and antioxidant
      activity. Exogenous melatonin has been used to treat insomnia and jet lag.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in anxiety level scores as assessed by the data collection sheet given to patients at all three time points (listed below)</measure>
    <time_frame>Anxiety levels will be assessed at check-in time (90 minutes before procedure), immediately before procedure, and 90 minutes post-operatively.</time_frame>
    <description>Comparing melatonin and placebo to see if differing levels of melatonin helps prevent or alleviate anxiety in service members undergoing an interventional pain procedure. For patients participating in the LMBB, anxiety level scores will be compared among the three time-points. Primary analysis will compare the two treatment groups versus placebo. The goal of this study is to demonstrate whether melatonin has anxiolytic effects preoperatively.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>2 mg Melatonin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To remain within the doses used for anxiolytic effects in past studies, we plan to study the effects of 2mg melatonin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 mg Melatonin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To remain within the doses used for anxiolytic effects in past studies, we plan to study the effects of 10mg melatonin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar Pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>To remain within the doses used for anxiolytic effects in past studies, we plan to study the effects of two different levels of melatonin versus placebo as premedication in patients undergoing a lumbar medial branch block (LMBB) procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>2 mg Melatonin</intervention_name>
    <description>40 patients will randomly receive 2 mg melatonin</description>
    <arm_group_label>2 mg Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10mg Melatonin</intervention_name>
    <description>40 patients will randomly receive 10 mg melatonin</description>
    <arm_group_label>10 mg Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>40 patients will randomly receive a placebo/sugar pill</description>
    <arm_group_label>Sugar Pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing LMBB procedure

          -  both genders between the ages of 18-50

        Exclusion Criteria:

          -  patients with active pregnancy (due to ionizing radiation)

          -  liver disease

          -  contraindications to LMBB procedure

          -  patient refusal

          -  localized or systemic infection

          -  low platelet count

          -  fibromyalgia

          -  use of sedative medications

          -  failure to comply with procedures

          -  investigator's determination that the assigned treatment is ineffective or unsafe

          -  appearance of unacceptable side effects in the subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ian M Fowler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United States Naval Medical Center, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ian M Fowler, MD</last_name>
    <phone>619-532-8943</phone>
    <email>ian.m.fowler.mil@mail.mil</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pain Medicine Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian M Fowler, MD</last_name>
      <phone>619-532-8943</phone>
      <email>ian.m.fowler.mil@mail.mil</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wheeler AH. Diagnosis and management of low back pain and sciatica. Am Fam Physician. 1995 Oct;52(5):1333-41, 1347-8. Review.</citation>
    <PMID>7572557</PMID>
  </reference>
  <reference>
    <citation>Slipman CW, Derby R, Simeone FA, et al. Slipman: Interventional Spine: An Algorithmic Approach, 1st ed. Elsevier Inc 2008.</citation>
  </reference>
  <reference>
    <citation>Wurtman R. Physiology and clinical use of melatonin. www.uptodate.com. Accessed 2/8/15.</citation>
  </reference>
  <reference>
    <citation>Cramer H, Rudolph J, Consbruch U, Kendel K. On the effects of melatonin on sleep and behavior in man. Adv Biochem Psychopharmacol. 1974;11(0):187-91.</citation>
    <PMID>4367644</PMID>
  </reference>
  <reference>
    <citation>Wurtman RJ, Zhdanova I. Improvement of sleep quality by melatonin. Lancet. 1995 Dec 2;346(8988):1491.</citation>
    <PMID>7491013</PMID>
  </reference>
  <reference>
    <citation>Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005 Feb;9(1):41-50.</citation>
    <PMID>15649737</PMID>
  </reference>
  <reference>
    <citation>Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. Review.</citation>
    <PMID>12076414</PMID>
  </reference>
  <reference>
    <citation>Acil M, Basgul E, Celiker V, Karagöz AH, Demir B, Aypar U. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol. 2004 Jul;21(7):553-7.</citation>
    <PMID>15318468</PMID>
  </reference>
  <reference>
    <citation>Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg. 2000 Aug;91(2):473-9.</citation>
    <PMID>10910871</PMID>
  </reference>
  <reference>
    <citation>Caumo W, Torres F, Moreira NL Jr, Auzani JA, Monteiro CA, Londero G, Ribeiro DF, Hidalgo MP. The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2007 Nov;105(5):1263-71, table of contents.</citation>
    <PMID>17959953</PMID>
  </reference>
  <reference>
    <citation>Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg. 2009 Apr;108(4):1146-51. doi: 10.1213/ane.0b013e3181907ebe.</citation>
    <PMID>19299777</PMID>
  </reference>
  <reference>
    <citation>Moerman N, van Dam FS, Muller MJ, Oosting H. The Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anesth Analg. 1996 Mar;82(3):445-51.</citation>
    <PMID>8623940</PMID>
  </reference>
  <reference>
    <citation>Melatonin Monograph. http://www.naturaldatabase.com/(S(nqojvt553k2ihb45ojhbdwu1))/nd/Search.aspx?cs=CPCE&amp;s=ND&amp;pt=100&amp;id=940&amp;ds=&amp;name=MELATONIN&amp;searchid=17337409. Accessed 2/3/15.</citation>
  </reference>
  <reference>
    <citation>Ahmad RA, Samarkandi A, Al-Mansouri SM, Obeidan SA. Sedation characteristics of melatonin and midazolam for premedication of adult patients undergoing cataract surgery under local anesthesia. Saudi Journal of Anesthesia 2007;1(1):6.</citation>
  </reference>
  <reference>
    <citation>Bajaj P. Melatonin for anxiolysis in children. Indian J Anaesth 2009;53:504-5.</citation>
  </reference>
  <reference>
    <citation>Kucukakin, B. Modification of surgical stress response by perioperative melatonin administration. PhD Thesis for Department of Surgical Gastroenterology, University of Copenhagen,</citation>
  </reference>
  <reference>
    <citation>Kurdi MS, Patel T. The role of melatonin in anaesthesia and critical care. Indian J Anaesth. 2013 Mar;57(2):137-44. doi: 10.4103/0019-5049.111837.</citation>
    <PMID>23825812</PMID>
  </reference>
  <reference>
    <citation>Samarkandi A, Naguib M, Riad W, Thalaj A, Alotibi W, Aldammas F, Albassam A. Melatonin vs. midazolam premedication in children: a double-blind, placebo-controlled study. Eur J Anaesthesiol. 2005 Mar;22(3):189-96.</citation>
    <PMID>15852991</PMID>
  </reference>
  <reference>
    <citation>Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F. Efficacy and safety of melatonin as an anxiolytic and analgesic in the perioperative period: a qualitative systematic review of randomized trials. Anesthesiology. 2010 Oct;113(4):968-76. doi: 10.1097/ALN.0b013e3181e7d626. Review.</citation>
    <PMID>20823763</PMID>
  </reference>
  <reference>
    <citation>Andersen LP, Rosenberg J, Gögenur I. Perioperative melatonin: not ready for prime time. Br J Anaesth. 2014 Jan;112(1):7-8. doi: 10.1093/bja/aet332.</citation>
    <PMID>24318695</PMID>
  </reference>
  <reference>
    <citation>Capuzzo M, Zanardi B, Schiffino E, Buccoliero C, Gragnaniello D, Bianchi S, Alvisi R. Melatonin does not reduce anxiety more than placebo in the elderly undergoing surgery. Anesth Analg. 2006 Jul;103(1):121-3, table of contents.</citation>
    <PMID>16790638</PMID>
  </reference>
  <reference>
    <citation>Pokharel K, Tripathi M, Gupta PK, Bhattarai B, Khatiwada S, Subedi A. Premedication with oral alprazolam and melatonin combination: a comparison with either alone--a randomized controlled factorial trial. Biomed Res Int. 2014;2014:356964. doi: 10.1155/2014/356964. Epub 2014 Jan 12.</citation>
    <PMID>24527443</PMID>
  </reference>
  <reference>
    <citation>Kennedy DJ, Schneider B, Casey E, Rittenberg J, Conrad B, Smuck M, Plastaras CT. Vasovagal rates in flouroscopically guided interventional procedures: a study of over 8,000 injections. Pain Med. 2013 Dec;14(12):1854-9. doi: 10.1111/pme.12241. Epub 2013 Oct 4.</citation>
    <PMID>24118835</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2015</study_first_posted>
  <last_update_submitted>August 18, 2016</last_update_submitted>
  <last_update_submitted_qc>August 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Melatonin</keyword>
  <keyword>Lumbar medial branch block (LMBB)</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Interventional Pain</keyword>
  <keyword>Pain Procedure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

